Toxic Docs
Blog
Acknowledgements
About
Favorites
Blog
Acknowledgments
About
Favorites
Document 3JR1qON4DO6oeDeZLv5v3q1Ka
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma